logo dark logo light logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS
    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
logo dark logo light logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS
    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
mobile-logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS

    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
27 Jun

Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule.

by Danni Sweeting
in 2025 News, Commercial, News, USA News
Comments

27 June 2025.

Atmo Biosciences is delighted to announce that it has received US Food and Drug Administration (FDA) 510(k) clearance for the Atmo Gas Capsule System, paving the way for its first product to be marketed and sold in the USA.

Continue reading
Read More

Contact

info@atmobiosciences.com

Australia

436 Elgar Rd
Box Hill VIC 3128

6 Middlemiss St
Lavender Bay NSW 2060

United States

3218 Third Avenue
San Diego CA 92103 USA
  • Clinician Portal Login
  • Support and Resources
  • Privacy Policy
  • USA
  • Terms and Conditions of Sale
  • Business Associate Agreement

© Atmo Biosciences 2026

loading

Please wait while you are redirected to the right region...